GSE173116 GSE173118 ML-7 1 v 7 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE173116_GSE173118_ML-7_1_v_7_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE173116_GSE173118_ML-7_1_v_7_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE173116_GSE173118_ML-7_1_v_7_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE173116_GSE173118_ML-7_1_v_7_human_up.

Results found

Linked to

 

Label

Description

 

Gene

G protein signaling modulator 3

Gene

taxilin gamma Y-linked (pseudogene)

Gene

P2Y receptor family member 8

Gene

long intergenic non-protein coding RNA 2910

Gene

TALAM1 transcript, MALAT1 antisense RNA

Gene

uncharacterized LOC339260

Gene

NIPBL divergent transcript

Gene

H2B clustered histone 19, pseudogene

Gene

ZNF528 antisense RNA 1

Gene

HOXA11 antisense RNA

  • Gene

    G protein signaling modulator 3


  • Gene

    taxilin gamma Y-linked (pseudogene)


  • Gene

    P2Y receptor family member 8


  • Gene

    long intergenic non-protein coding RNA 2910


  • Gene

    TALAM1 transcript, MALAT1 antisense RNA


  • Gene

    uncharacterized LOC339260


  • Gene

    NIPBL divergent transcript


  • Gene

    H2B clustered histone 19, pseudogene


  • Gene

    ZNF528 antisense RNA 1


  • Gene

    HOXA11 antisense RNA

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.